Coastlands Capital Partners LP - 28 May 2025 SCHEDULE 13G Report for AN2 Therapeutics, Inc. Common Stock (ANTX)

Filing Manager
Coastlands Capital Partners LP
Reporting Manager
Coastlands Capital LP
Security
AN2 Therapeutics, Inc. Common Stock
Symbol
ANTX
Shares outstanding
30,278,495 shares
Disclosed Ownership
2,815,900 shares
Ownership
9.3%
Form type
SCHEDULE 13G
Filing time
04 Jun 2025, 17:44:09 UTC
Date of event
28 May 2025
SEC
View on sec.gov

Quoteable Key Fact

"Coastlands Capital Partners LP disclosed 9.3% ownership in AN2 Therapeutics, Inc. Common Stock (ANTX) on 28 May 2025."

Quick Takeaways

  • Coastlands Capital Partners LP filed SCHEDULE 13G for AN2 Therapeutics, Inc. Common Stock (ANTX).
  • Disclosed ownership: 9.3%.
  • Date of event: 28 May 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Jun 2025, 17:44.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Coastlands Capital LP 9.3% 2,815,900 0 2,815,900 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital LLC
Coastlands Capital Partners LP 9.3% 2,815,900 0 2,815,900 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Coastlands Capital GP LLC 9.3% 2,815,900 2,815,900 0 /s/ Mark Shamia Chief Operating Officer
Coastlands Capital LLC 9.3% 2,815,900 0 2,815,900 /s/ Mark Shamia Chief Operating Officer
Matthew D. Perry 9.3% 2,815,900 0 2,815,900 /s/ Matthew D. Perry Reporting person